AstraZeneca inks $1.5B license deal for lung cancer drug

3 Reasons NIC Has Explosive Upside Potential

2026/07/14

U.S. airstrikes on Iran trigger Middle East retaliation; crude spikes

2026/07/14

Ericsson tumbles 9% on Q2 revenue miss and rising AI costs

2026/07/14

Crude rallies: WTI tops $80 as fresh U.S.-Iran clashes spark supply fears

2026/07/14